Cargando…

Cervical cancer screening in HIV-endemic countries: An urgent call for guideline change

Women living with HIV (WLWH) are at an increased risk of developing HPV-related high grade cervical dysplasia and cervical cancer. Prior World Health Organization (WHO) screening guidelines recommended starting screening at age 30. We assessed characteristics of women diagnosed with cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grover, Surbhi, Bhatia, Rohini, Friebel-Klingner, Tara M., Mathoma, Anikie, Vuylsteke, Peter, Khan, Salman, Ralefala, Tlotlo, Tawe, Leabaneng, Bazzett-Matabele, Lisa, Monare, Barati, Luckett, Rebecca, Ramogola-Masire, Doreen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999385/ https://www.ncbi.nlm.nih.gov/pubmed/36682141 http://dx.doi.org/10.1016/j.ctarc.2023.100682

Ejemplares similares

Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

Neoadjuvant chemotherapy and less invasive surgery for the management of early stage cervical cancer: A brief report from Botswana
por: Grover, Surbhi, et al.
Publicado: (2022)

Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study
por: Rendle, Katharine A., et al.
Publicado: (2022)

Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana
por: Friebel-Klingner, Tara M., et al.
Publicado: (2021)

Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV
por: Friebel-Klingner, Tara M., et al.
Publicado: (2022)

Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020
por: Grover, Surbhi, et al.
Publicado: (2022)

Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana
por: Friebel-Klingner, Tara M., et al.
Publicado: (2022)

Gynecologic Cancer: New and Follow-Up Patient Appointments in Botswana During the COVID-19 Pandemic
por: Davey, Sonya, et al.
Publicado: (2021)

Patterns of care and outcomes for endometrial and ovarian cancers in botswana 2015–2021
por: Lumley, Christian, et al.
Publicado: (2023)

A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa
por: Kambhampati, Aparna, et al.
Publicado: (2023)

Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology
por: Grover, Surbhi, et al.
Publicado: (2023)

HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
por: McClung, Nancy, et al.
Publicado: (2022)

Human papillomavirus prevalence in male and female university students in Gaborone, Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting
por: Martei, Yehoda M., et al.
Publicado: (2019)

Comparison of the AmpFire(®) Multiplex HPV Assay to the Xpert(®) HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation
por: Moyo, Sikhulile, et al.
Publicado: (2023)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
por: Moyo, Sikhulile, et al.
Publicado: (2023)

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Development and launch of the first obstetrics and gynaecology master of medicine residency training programme in Botswana
por: Luckett, R., et al.
Publicado: (2021)

Factors Related to Advanced Stage of Cancer Presentation in Botswana
por: Anakwenze, Chidinma, et al.
Publicado: (2018)

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018)

Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana
por: Bhatia, Rohini K., et al.
Publicado: (2018)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2010)

Advancing oncology drug therapies for sub-Saharan Africa
por: Sharma, Kirthana, et al.
Publicado: (2023)

Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa
por: Motlokwa, Precious K., et al.
Publicado: (2022)

Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting
por: Brown, Carolyn A., et al.
Publicado: (2016)

Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model for Multidisciplinary Oncology Care in Low- and Middle-Income Settings
por: Grover, Surbhi, et al.
Publicado: (2017)

Provider Barriers and Facilitators of Breast Cancer Guideline‐Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis
por: Ralefala, Tlotlo, et al.
Publicado: (2021)

Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
por: Martei, Yehoda M., et al.
Publicado: (2022)

Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer
por: Sobota, Rafal S, et al.
Publicado: (2014)

Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana
por: Barchi, Francis, et al.
Publicado: (2019)

Breast Cancer Pathology Turnaround Time in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2017)

Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana
por: MacDuffie, Emily, et al.
Publicado: (2021)

Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana
por: Davey, Sonya, et al.
Publicado: (2021)

Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study
por: Iyer, Hari S., et al.
Publicado: (2019)

Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review
por: Bango, Zackary Austin, et al.
Publicado: (2020)

Healthcare provider challenges to early detection of cervical cancer at primary healthcare level in Rwanda
por: Nkurunziza, Charles, et al.
Publicado: (2021)

A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana
por: DiAngi, Yumi Taylor, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q8dfhh59qdjr22is4d73cvpoov